Rainbow Childrens Medicare logo

Rainbow Childrens Medicare MD, chairman, board of directors and AGM

NSE: RAINBOWBSE: 543524Healthcare ServicesSmall Cap

Last close ₹1,169.60down ₹30.10 (2.51%)BSE ₹1,169.30

Share price at the NSE close on 23 Oct 2026. Previous close ₹1,199.70.

52-week range of traded prices to 23 Oct 2026
₹1,084.00Low, 23 Mar 2026₹1,610.00High, 5 Aug 2026
Market cap
₹11,879 Cr481st largest listed
P/E
41.6
P/B
7.2
Dividend yield
0.30%
ROE
18.3%
ROCE
25.0%
Debt to equity
0.00
Volume, NSE
79,76056.6% delivered

Rainbow Childrens Medicare board of directors

At the end of the quarter to Jun 2026, as the company filed it; changes since are in its announcements.Their trades in its shares

  • Chairperson and managing directorRamesh Kancharla
  • Company Secretary and Compliance OfficerShreya Mitra

7 directors4 independent2 executive1 non-executive

  • Ramesh Kancharla · Chairperson and managing directorExecutive · joined Aug 1998 · reappointed Aug 2021 · 1 listed board · 2 committee seats
  • Ch Dinesh KumarExecutive · joined Dec 2005 · reappointed Aug 2021 · 1 listed board
  • Adarsh KancharlaNon-executive · joined Jan 2024 · reappointed Jan 2024 · 1 listed board
  • Anil DhawanIndependent · joined Aug 2018 · reappointed Aug 2023 · 94 months as independent · 1 listed board · 1 as independent · 2 committee seats
  • Aluri Srinivasa RaoIndependent · joined Mar 2019 · reappointed Mar 2024 · 87 months as independent · 1 listed board · 1 as independent · 2 committee seats
  • Sundari R PisupatiIndependent · joined Sep 2021 · reappointed Sep 2021 · 57 months as independent · 1 listed board · 1 as independent · 5 committee seats, 2 as chair
  • Santanu MukherjeeIndependent · joined Oct 2021 · reappointed Oct 2021 · 56 months as independent · 4 listed boards · 4 as independent · 8 committee seats, 5 as chair

An independent director has no business or family tie to the company, its promoters or its managers beyond the seat. Listed boards counts the boards of listed companies the director sits on, this one included, and "as independent" how many of those seats are independent ones. Committee seats are audit and stakeholder committee seats across those companies. Months as independent is filed for independent directors only, whose terms the rules cap. Disqualified is the company's own mark that a director may not serve under company law.

Committees and meetings

Who sits on each, and how often they met.Board meeting notices and outcomes

  • Board

    • 23 May 20266 of 7 present3 independent · 55 days in between
    • 28 Mar 20266 of 7 present4 independent · 58 days in between
    • 28 Jan 20266 of 7 present4 independent

  • Audit Committee

    Chair Santanu Mukherjee

    Anil Dhawan, Aluri Srinivasa Rao, Sundari R Pisupati

    • 23 May 20263 of 4 present3 independent · 114 days in between
    • 28 Jan 20264 of 4 present4 independent

  • Nomination and remuneration committee

    Chair Aluri Srinivasa Rao

    Anil Dhawan, Sundari R Pisupati, Santanu Mukherjee

    • 23 May 20263 of 4 present3 independent · 114 days in between
    • 28 Jan 20264 of 4 present4 independent

  • Stakeholders Relationship Committee

    Chair Sundari R Pisupati

    Ramesh Kancharla, Anil Dhawan, Aluri Srinivasa Rao

    No meeting listed in the filing.

  • Risk Management Committee

    Chair Santanu Mukherjee

    Ramesh Kancharla, Adarsh Kancharla, Aluri Srinivasa Rao, Vikas Maheshwari, Srinath Metla, Abrarali Dalal

    • 28 Mar 20263 of 4 present2 independent

  • Corporate Social Responsibility Committee

    Chair Anil Dhawan

    Ramesh Kancharla, Ch Dinesh Kumar, Adarsh Kancharla, Sundari R Pisupati, Santanu Mukherjee

    • 23 May 20266 of 6 present3 independent

Meetings in the quarter filed and the one before it. The days in between are as the company files them, neither meeting's day counted; the rules allow at most 120. A quorum is the least number of members who must attend for the meeting to decide anything.

Statutory auditor

Named in the results for the quarter to Jun 2026.

  • S.R. BATLIBOI & ASSOCIATES LLPPeer-review certificate valid to Jul 2027

A statutory auditor checks the company's accounts and signs its results. Peer review is the accountants' institute's check of an audit firm's own work, which a listed company's auditor must hold a valid certificate of.

Rainbow Childrens Medicare AGM and shareholder votes

Each resolution, how the votes went, and how institutions voted apart from the promoters. A postal ballot is a vote by post or online, held without a meeting.Rainbow Childrens Medicare dividend history

Annual general meeting, 29 Jul 2026

90,558 shareholders on the register on 22 Jul 2026; present: 6 promoters and 57 others; votes counted by K.V.S. Subramanyam / M/s. KVSS & CO. LLP.The company's voting result (opens in a new tab)

  1. To receive, consider and adopt the Audited Standalone Financial statements of the Company for the Financial Year ended March 31, 2026, the reports of the Auditors and Board of Directors thereon and the Audited Consolidated Financial statements of the Company for the Financial Year ended March 31, 2026 and the report of the Auditors thereon.MoreLess
    Ordinary
    100.00% for0.00% against

    Against: promoters 0.00% · institutions 0.00% · other public 0.00%

    Turnout: all 89.46% · promoters 100.00% · institutions 89.71% · other public 43.16%

  2. To declare dividend of Rs.3.5/- per Equity Share for the Financial Year ended March 31, 2026.
    Ordinary
    100.00% for0.00% against

    Against: promoters 0.00% · institutions 0.00% · other public 0.00%

    Turnout: all 89.46% · promoters 100.00% · institutions 89.71% · other public 43.16%

  3. To appoint a director in place of Dr. Adarsh Kancharla (DIN: 08302615), who retires by rotation and being eligible, offers himself for re-appointment.
    OrdinaryPromoters have an interest in it
    68.23% for31.77% against

    Against: promoters 0.00% · institutions 43.37% · other public 0.02%

    Turnout: all 47.29% · promoters 15.38% · institutions 89.71% · other public 43.16%

  4. To ratify the remuneration payable to Cost Auditors for the Financial Year 2026-27.
    Ordinary
    100.00% for0.00% against

    Against: promoters 0.00% · institutions 0.00% · other public 0.00%

    Turnout: all 89.46% · promoters 100.00% · institutions 89.71% · other public 43.16%

  5. To consider, review and approve the re-appointment of Dr. Ramesh Kancharla (DIN: 00212270), Chairman and Managing Director of the Company.
    OrdinaryPromoters have an interest in it
    99.90% for0.10% against

    Against: promoters 0.00% · institutions 0.13% · other public 0.01%

    Turnout: all 47.29% · promoters 15.38% · institutions 89.71% · other public 43.16%

  6. To consider, review and approve the remuneration payable to Dr. Ramesh Kancharla (DIN: 00212270), as Chairman and Managing Director of the Company.
    SpecialPromoters have an interest in it
    100.00% for0.00% against

    Against: promoters 0.00% · institutions 0.00% · other public 0.01%

    Turnout: all 47.29% · promoters 15.38% · institutions 89.71% · other public 43.16%

  7. To consider review and approve the re-appointment of Dr. Dinesh Kumar Chirla (DIN: 01395841), Whole-time Director of the Company.
    OrdinaryPromoters have an interest in it
    100.00% for0.00% against

    Against: promoters 0.00% · institutions 0.00% · other public 0.01%

    Turnout: all 82.93% · promoters 86.90% · institutions 89.71% · other public 43.16%

  8. To consider and approve the payment of remuneration to Dr. Dinesh Kumar Chirla (DIN: 01395841), Whole-time Director of the Company.
    SpecialPromoters have an interest in it
    100.00% for0.00% against

    Against: promoters 0.00% · institutions 0.00% · other public 0.02%

    Turnout: all 82.93% · promoters 86.90% · institutions 89.71% · other public 43.16%

  9. To consider, approve and recommend for the re-appointment of Mr. Santanu Mukherjee (DIN: 07716452), as an Independent Director of the Company.
    Special
    97.14% for2.86% against

    Against: promoters 0.00% · institutions 7.38% · other public 0.01%

    Turnout: all 89.46% · promoters 100.00% · institutions 89.71% · other public 43.16%

  10. To consider, approve and recommend for the re-appointment of Ms. Sundari R. Pisupati (DIN: 01908852), as an Independent Director of the Company.
    Special
    97.11% for2.89% against

    Against: promoters 0.00% · institutions 7.46% · other public 0.01%

    Turnout: all 89.46% · promoters 100.00% · institutions 89.71% · other public 43.16%

For and against are per cent of the votes cast. Turnout is the votes cast as a per cent of the shares each group holds. Institutions are funds, insurers, banks and foreign investors. An ordinary resolution passes with more than half the votes cast, a special one with at least three quarters.

Postal ballot, 27 Sep 2025, 1 resolution

80,519 shareholders on the register on 22 Aug 2025; votes counted by Kodukula Venkata Srinivasa Subramanyam / KVSS & CO. LLP.The company's voting result (opens in a new tab)

  1. Approval for giving loans under Section 185 of the Companies Act, 2013
    Special
    98.37% for1.63% against

    Against: promoters 0.00% · institutions 4.26% · other public 0.06%

    Turnout: all 88.53% · promoters 100.00% · institutions 85.30% · other public 46.40%

For and against are per cent of the votes cast. Turnout is the votes cast as a per cent of the shares each group holds. Institutions are funds, insurers, banks and foreign investors. An ordinary resolution passes with more than half the votes cast, a special one with at least three quarters.

Annual general meeting, 5 Jul 2025, 7 resolutions

81,412 shareholders on the register on 28 Jun 2025; present: 6 promoters and 51 others; votes counted by K.V.S. Subramanyam / KVSS & CO LLP.The company's voting result (opens in a new tab)

  1. To receive, consider and adopt the Audited Standalone Financial statements of the Company for the Financial Year ended March 31, 2025, the reports of the Auditors and Board of Directors thereon and the Audited Consolidated Financial statements of the Company for the Financial Year ended March 31, 2025 and the report of the Auditors thereon.MoreLess
    Ordinary
    100.00% for0.00% against

    Against: promoters 0.00% · institutions 0.00% · other public 0.00%

    Turnout: all 87.84% · promoters 100.00% · institutions 84.89% · other public 43.67%

  2. To declare dividend of Rs. 3/- per Equity Share for the Financial Year ended March 31, 2025.
    Ordinary
    100.00% for0.00% against

    Against: promoters 0.00% · institutions 0.00% · other public 0.00%

    Turnout: all 87.84% · promoters 100.00% · institutions 84.89% · other public 43.67%

  3. To appoint a Director in place of Dr. Dinesh Kumar Chirla (DIN: 01395841), who retires by rotation and being eligible offers himself for re-appointment.
    Ordinary
    99.97% for0.03% against

    Against: promoters 0.00% · institutions 0.08% · other public 0.01%

    Turnout: all 87.84% · promoters 100.00% · institutions 84.89% · other public 43.67%

  4. To ratify the remuneration payable to Cost Auditors for the Financial Year 2025-26.
    Ordinary
    99.89% for0.11% against

    Against: promoters 0.00% · institutions 0.30% · other public 0.00%

    Turnout: all 87.84% · promoters 100.00% · institutions 84.89% · other public 43.67%

  5. To appoint Secretarial Auditor of the Company for a term of 5 (five) consecutive years from FY 2025-26.
    Ordinary
    99.89% for0.11% against

    Against: promoters 0.00% · institutions 0.30% · other public 0.00%

    Turnout: all 87.84% · promoters 100.00% · institutions 84.89% · other public 43.67%

  6. To approve increase in commission payable to Non-Executive Directors (including Independent Directors) of the Company.
    Ordinary
    99.47% for0.53% against

    Against: promoters 0.00% · institutions 1.39% · other public 0.10%

    Turnout: all 87.84% · promoters 100.00% · institutions 84.89% · other public 43.67%

  7. To approve increase in the limits applicable for making investments/ extending loans and giving guarantees or providing securities in connection with loans to persons/ bodies corporate
    Special
    85.57% for14.43% against

    Against: promoters 0.00% · institutions 40.43% · other public 0.01%

    Turnout: all 85.07% · promoters 100.00% · institutions 77.80% · other public 43.67%

For and against are per cent of the votes cast. Turnout is the votes cast as a per cent of the shares each group holds. Institutions are funds, insurers, banks and foreign investors. An ordinary resolution passes with more than half the votes cast, a special one with at least three quarters.

Postal ballot, 2 Apr 2025, 4 resolutions

79,890 shareholders on the register on 28 Feb 2025; votes counted by Kodukula Venkata Srinivasa Subramanyam / KVSS & CO. LLP.The company's voting result (opens in a new tab)

  1. Approval of 'Rainbow Children's Medicare Limited - Employee Stock Option Scheme 2025'.
    Special
    86.10% for13.90% against

    Against: promoters 0.00% · institutions 37.25% · other public 0.06%

    Turnout: all 87.44% · promoters 100.00% · institutions 83.63% · other public 44.60%

  2. Approval for grant of Options to the employees of the subsidiary Compan(ies) of the Company under 'Rainbow Children's Medicare Limited Employee Stock Option Scheme 2025'’.
    Special
    86.13% for13.87% against

    Against: promoters 0.00% · institutions 37.18% · other public 0.07%

    Turnout: all 87.44% · promoters 100.00% · institutions 83.63% · other public 44.60%

  3. Approval for secondary acquisition of shares through Trust route for the implementation of 'Rainbow Children's Medicare Limited Employee Stock Option Scheme 2025'.’
    Special
    86.22% for13.78% against

    Against: promoters 0.00% · institutions 36.93% · other public 0.07%

    Turnout: all 87.44% · promoters 100.00% · institutions 83.63% · other public 44.60%

  4. Approval for provision of money by the Company for purchase of its own Shares by the Trust under the 'Rainbow Children's Medicare Limited Employee Stock Option Scheme 2025'.
    Special
    86.25% for13.75% against

    Against: promoters 0.00% · institutions 36.86% · other public 0.07%

    Turnout: all 87.44% · promoters 100.00% · institutions 83.63% · other public 44.60%

For and against are per cent of the votes cast. Turnout is the votes cast as a per cent of the shares each group holds. Institutions are funds, insurers, banks and foreign investors. An ordinary resolution passes with more than half the votes cast, a special one with at least three quarters.

Annual general meeting, 30 Jul 2024, 6 resolutions

Present: 7 promoters and 60 others.The company's voting result (opens in a new tab)

  1. To receive, consider and adopt the Audited Standalone Financial statements of the Company for the Financial Year ended March 31, 2024, the reports of the Auditors and Board of Directors thereon and the Audited Consolidated Financial statements of the Company for the Financial Year ended March 31, 2024 and the report of the Auditors thereon.MoreLess
    Ordinary
    100.00% for0.00% against

    Against: promoters 0.00% · institutions 0.00% · other public 0.01%

    Turnout: all 86.79% · promoters 100.00% · institutions 82.76% · other public 44.36%

  2. To declare dividend of ₹ 3/- per Equity Share for the Financial Year ended March 31, 2024.
    Ordinary
    99.79% for0.21% against

    Against: promoters 0.00% · institutions 0.58% · other public 0.00%

    Turnout: all 86.79% · promoters 100.00% · institutions 82.76% · other public 44.35%

  3. To appoint a Director in place of Dr. Ramesh Kancharla (DIN: 00212270), who retires by rotation
    Ordinary
    96.54% for3.46% against

    Against: promoters 0.00% · institutions 9.77% · other public 0.01%

    Turnout: all 85.28% · promoters 100.00% · institutions 78.80% · other public 44.35%

  4. To approve the remuneration payable to Dr. Ramesh Kancharla, Chairman and ManagingnDirector of the Company.
    Special
    98.66% for1.34% against

    Against: promoters 0.00% · institutions 3.68% · other public 0.02%

    Turnout: all 86.79% · promoters 100.00% · institutions 82.76% · other public 44.35%

  5. To approve the remuneration payable to Dr. Dinesh Kumar Chirla, Whole-Time Directornof the Company.
    Special
    100.00% for0.00% against

    Against: promoters 0.00% · institutions 0.00% · other public 0.03%

    Turnout: all 86.79% · promoters 100.00% · institutions 82.76% · other public 44.35%

  6. To ratify the remuneration payable to Cost Auditors for the Financial Year 2024-25.
    Ordinary
    100.00% for0.00% against

    Against: promoters 0.00% · institutions 0.00% · other public 0.01%

    Turnout: all 86.79% · promoters 100.00% · institutions 82.76% · other public 44.35%

For and against are per cent of the votes cast. Turnout is the votes cast as a per cent of the shares each group holds. Institutions are funds, insurers, banks and foreign investors. An ordinary resolution passes with more than half the votes cast, a special one with at least three quarters.

Postal ballot, 16 Mar 2024, 1 resolution

The company's voting result (opens in a new tab)

  1. Appointment of Dr. Adarsh Kancharla (DIN: 08302615), as a Non-Executive Director of the Company
    Ordinary
    84.61% for15.39% against

    Against: promoters 0.00% · institutions 41.86% · other public 0.02%

    Turnout: all 87.38% · promoters 100.00% · institutions 83.88% · other public 45.71%

For and against are per cent of the votes cast. Turnout is the votes cast as a per cent of the shares each group holds. Institutions are funds, insurers, banks and foreign investors. An ordinary resolution passes with more than half the votes cast, a special one with at least three quarters.

Postal ballot, 23 Dec 2023, 1 resolution

The company's voting result (opens in a new tab)

  1. Re-appointment of Mr. Aluri Srinivasa Rao (DIN: 00147058), as an Independent Director of the Company for a term of Five (5) years commencing from March 15, 2024.
    Special
    97.77% for2.23% against

    Against: promoters 0.00% · institutions 6.09% · other public 0.04%

    Turnout: all 85.01% · promoters 100.00% · institutions 82.58% · other public 32.95%

For and against are per cent of the votes cast. Turnout is the votes cast as a per cent of the shares each group holds. Institutions are funds, insurers, banks and foreign investors. An ordinary resolution passes with more than half the votes cast, a special one with at least three quarters.

Annual general meeting, 29 Jun 2023, 6 resolutions

Present: 5 promoters and 49 others.The company's voting result (opens in a new tab)

  1. To receive, consider and adopt the Audited Standalone Financial statements of the Company for the Financial Year ended March 31, 2023, the reports of the Auditors and Board of Directors thereon and the Audited Consolidated Financial statements of the Company for the Financial Year ended March 31, 2023 and the report of the Auditors thereon.MoreLess
    Ordinary
    100.00% for0.00% against

    Against: promoters 0.00% · institutions 0.00% · other public 0.00%

    Turnout: all 81.35% · promoters 100.00% · institutions 74.01% · other public 35.70%

  2. To declare dividend of ₹ 3/- per Equity Share for the Financial Year ended March 31, 2023.
    Ordinary
    100.00% for0.00% against

    Against: promoters 0.00% · institutions 0.00% · other public 0.00%

    Turnout: all 81.38% · promoters 100.00% · institutions 74.09% · other public 35.70%

  3. To appoint a Director in place of Dr. Dinesh Kumar Chirla (DIN: 01395841), who retires by rotation and being eligible offers himself for re-appointment.
    OrdinaryPromoters have an interest in it
    100.00% for0.00% against

    Against: promoters 0.00% · institutions 0.00% · other public 0.01%

    Turnout: all 81.38% · promoters 100.00% · institutions 74.09% · other public 35.70%

  4. To appoint M/s. S.R. Batliboi & Associates LLP (Firm Registration No. 101049W/ E300004), Chartered Accountants, as Statutory Auditors for a term of 5 (five) consecutive years and to fix their remuneration.MoreLess
    OrdinaryPromoters have an interest in it
    97.55% for2.45% against

    Against: promoters 0.00% · institutions 7.58% · other public 0.01%

    Turnout: all 81.38% · promoters 100.00% · institutions 74.09% · other public 35.70%

  5. nTo re-appoint Dr. Anil Dhawan (DIN: 08191702), as an Independent Director of the Company for a term of 5 (Five) years commencing from August 30, 2023.n
    Special
    97.45% for2.55% against

    Against: promoters 0.00% · institutions 7.87% · other public 0.02%

    Turnout: all 81.38% · promoters 100.00% · institutions 74.09% · other public 35.70%

  6. To ratify the remuneration payable to Cost Auditors for the Financial Year 2023-24.
    Ordinary
    100.00% for0.00% against

    Against: promoters 0.00% · institutions 0.00% · other public 0.01%

    Turnout: all 81.38% · promoters 100.00% · institutions 74.09% · other public 35.70%

For and against are per cent of the votes cast. Turnout is the votes cast as a per cent of the shares each group holds. Institutions are funds, insurers, banks and foreign investors. An ordinary resolution passes with more than half the votes cast, a special one with at least three quarters.

How mutual funds voted

Fund houses must disclose how they vote at every meeting of a company they hold.Funds that hold it

Mutual fund votes, meeting of 29 Jul 2026, 10 fund houses so far (houses' deadline to file 15 Oct 2026)

  • To receive, consider and adopt the Audited Standalone Financial statements of the Company for the Financial Year ended March 31, 2026, the reports of the Auditors and Board of Directors thereon and the Audited Consolidated Financial statements of the Company for the Financial Year ended March 31, 2026 and the report of the Auditors thereon.MoreLess
    10 for0 against
  • To declare dividend of Rs.3.5/- per Equity Share for the Financial Year ended March 31, 2026.
    10 for0 against
  • To appoint a director in place of Dr. Adarsh Kancharla (DIN: 08302615), who retires by rotation and being eligible, offers himself for re-appointment.
    Against Angel One Mutual Fund, DSP Mutual Fund, Edelweiss Mutual Fund, Jio BlackRock Mutual Fund, Navi Mutual Fund
    • Angel One Mutual FundGovernance concern: Low attendance at Board meetings held during FY 2025-26 and also Low attendance at Risk Management Committee and no justification has been provided by the Company for his leave of absence.
    • DSP Mutual Fund, Jio BlackRock Mutual FundDr. Adarsh Kancharla, 30, is promoter and is the son of promoter and Managing Director, Ramesh Kancharla. He has completed an MBBS and MD in Paediatrics from Sri Ramachandra Institute, Chennai in 2022 and after completing his post-graduation in 2022 he was working with Rainbow Children’s Hospital before completing a Fellowship at Kings College Hospital, London between March 2024 and March 2025. He is currently pursuing his MBA from Harvard Business School. He has been on board since 24 January 2024 as a Non-Executive Non-Independent Director. He has attended three out of six (50%) board meetings held in FY26 and ten out of thirteen (77%) board meetings from date of his first appointment. We expect directors to attend all board meetings during the year and have an attendance threshold of 75% of the board meetings. While his appointment is in line with the statutory requirements, we note that with an aggregate work experience of less than ten years, his reappointment does not align with our voting guidelines. We do not support the resolution.
    • Edelweiss Mutual Fund, Navi Mutual FundCompliant with law. No concern on the merit of the proposed Director. Governance concern: Low attendance at Board meetings held during FY 2025-26 and also Low attendance at Risk Management Committee and no justification has been provided by the Company for his leave of absence.
    5 for5 against
  • To ratify the remuneration payable to Cost Auditors for the Financial Year 2026-27.
    10 for0 against
  • To consider, review and approve the re-appointment of Dr. Ramesh Kancharla (DIN: 00212270), Chairman and Managing Director of the Company.
    10 for0 against
  • To consider, review and approve the remuneration payable to Dr. Ramesh Kancharla (DIN: 00212270), as Chairman and Managing Director of the Company.
    10 for0 against
  • To consider review and approve the re-appointment of Dr. Dinesh Kumar Chirla (DIN: 01395841), Whole-time Director of the Company.
    10 for0 against
  • To consider and approve the payment of remuneration to Dr. Dinesh Kumar Chirla (DIN: 01395841), Whole-time Director of the Company.
    10 for0 against
  • To consider, approve and recommend for the re-appointment of Mr. Santanu Mukherjee (DIN: 07716452), as an Independent Director of the Company.
    10 for0 against
  • To consider, approve and recommend for the re-appointment of Ms. Sundari R. Pisupati (DIN: 01908852), as an Independent Director of the Company.
    10 for0 against

Mutual fund votes, meeting of 27 Sep 2025, 23 fund houses

Each resolution counts the houses whose vote was matched to it; the rest are listed last.

  • Approval for giving loans under Section 185 of the Companies Act, 2013
    4 for0 against
1 proposal not matched to one resolution
  • To advance any loan(s) including any loan represented by a book debt and/or give any guarantee(s) and/or provide any security(ies) in connection with any Financial assistance/ loan taken/ to be taken and/or credit facilities availed/ to be availed by the Companies (Borrowing Companies), in one or more tranches, in which certain Directors of the Company are interested upto an amount not exceeding in aggregate Rs. 35,00,00,000/- on such as the Board of Directors may deem beneficial in their absolute discretion and in the best interest of the Company.MoreLess
    Against Angel One Mutual Fund, Edelweiss Mutual Fund, Groww Mutual Fund, Navi Mutual Fund, PGIM India Mutual Fund
    • Angel One Mutual FundNon-disclosure of full particulars of the investment as required. Transparency Concern: Inadequate Disclosures with regards to interest of Directors in relevant entities in the Notice.
    • Edelweiss Mutual Fund, Groww Mutual Fund, Navi Mutual Fund, PGIM India Mutual FundNon-compliant w.r.t Companies Act, 2013: Non-disclosure of full particulars of the investment as required under Section 185 of Companies Act, 2013. Transparency Concern: Inadequate Disclosures w.r.t interest of Directors in relevant entities in the Notice.
    14 for5 against
6 earlier meetings

Mutual fund votes, meeting of 5 Jul 2025, 22 fund houses

  • To receive, consider and adopt the Audited Standalone Financial statements of the Company for the Financial Year ended March 31, 2025, the reports of the Auditors and Board of Directors thereon and the Audited Consolidated Financial statements of the Company for the Financial Year ended March 31, 2025 and the report of the Auditors thereon.MoreLess
    22 for0 against
  • To declare dividend of Rs. 3/- per Equity Share for the Financial Year ended March 31, 2025.
    22 for0 against
  • To appoint a Director in place of Dr. Dinesh Kumar Chirla (DIN: 01395841), who retires by rotation and being eligible offers himself for re-appointment.
    22 for0 against
  • To ratify the remuneration payable to Cost Auditors for the Financial Year 2025-26.
    22 for0 against
  • To appoint Secretarial Auditor of the Company for a term of 5 (five) consecutive years from FY 2025-26.
    22 for0 against
  • To approve increase in commission payable to Non-Executive Directors (including Independent Directors) of the Company.
    Against Mirae Asset Mutual Fund
    • Mirae Asset Mutual FundAs per advisory recommendation (Passive holding)
    21 for1 against
  • To approve increase in the limits applicable for making investments/ extending loans and giving guarantees or providing securities in connection with loans to persons/ bodies corporate
    Against Angel One Mutual Fund, Bandhan Mutual Fund, Edelweiss Mutual Fund, Groww Mutual Fund, HDFC Mutual Fund, HSBC Mutual Fund, Mirae Asset Mutual Fund, Motilal Oswal Mutual Fund, Navi Mutual Fund, Nippon India Mutual Fund, PGIM India Mutual Fund, UTI Mutual Fund
    • Angel One Mutual Fund, Edelweiss Mutual FundGovernance concern: Blanket approval sought without adequate disclosures.
    • Bandhan Mutual Fund, Groww Mutual Fund, Motilal Oswal Mutual Fund, Navi Mutual Fund, PGIM India Mutual FundCompliant with law. Governance concern: Blanket approval sought without adequate disclosures.
    • HDFC Mutual FundThe company has not disclosed the granular details for the financial support. We do not support this resolution.
    • HSBC Mutual FundA vote AGAINST this resolution is warranted due to lack of information.
    • Mirae Asset Mutual FundAs per advisory recommendation (Passive holding)
    • Nippon India Mutual FundTransparency concern: No adequate disclosure
    • UTI Mutual FundRationale unclear.
    10 for12 against

Mutual fund votes, meeting of 2 Apr 2025, 21 fund houses

  • Approval of 'Rainbow Children's Medicare Limited - Employee Stock Option Scheme 2025'.
    Against HDFC Mutual Fund, HSBC Mutual Fund
    • HDFC Mutual FundExercise price of the ESOP is at a discount to market price. We do not support the resolution.
    • HSBC Mutual FundA vote AGAINST the resolution is warranted because: • The scheme provides flexibility for grant of stock options with an exercise price, at a discount to the prevailing market price. • Although, the vesting may be performance based, there is no disclosure on the performance metrics, weights, targets and threshold for determining the vesting outcome.
    19 for2 against
  • Approval for grant of Options to the employees of the subsidiary Compan(ies) of the Company under 'Rainbow Children's Medicare Limited Employee Stock Option Scheme 2025'’.
    Against HDFC Mutual Fund, HSBC Mutual Fund
    • HDFC Mutual FundExercise price of the ESOP is at a discount to market price. We do not support the resolution.
    • HSBC Mutual FundA vote AGAINST the resolution is warranted because: • The scheme provides flexibility for grant of stock options with an exercise price, at a discount to the prevailing market price. • Although, the vesting may be performance based, there is no disclosure on the performance metrics, weights, targets and threshold for determining the vesting outcome.
    19 for2 against
  • Approval for secondary acquisition of shares through Trust route for the implementation of 'Rainbow Children's Medicare Limited Employee Stock Option Scheme 2025'.’
    Against HDFC Mutual Fund, HSBC Mutual Fund
    • HDFC Mutual FundExercise price of the ESOP is at a discount to market price. We do not support the resolution.
    • HSBC Mutual FundA vote AGAINST the resolution is warranted because: • The scheme provides flexibility for grant of stock options with an exercise price, at a discount to the prevailing market price. • Although, the vesting may be performance based, there is no disclosure on the performance metrics, weights, targets and threshold for determining the vesting outcome.
    19 for2 against
  • Approval for provision of money by the Company for purchase of its own Shares by the Trust under the 'Rainbow Children's Medicare Limited Employee Stock Option Scheme 2025'.
    Against HDFC Mutual Fund, HSBC Mutual Fund
    • HDFC Mutual FundExercise price of the ESOP is at a discount to market price. We do not support the resolution.
    • HSBC Mutual FundA vote AGAINST the resolution is warranted because: • The scheme provides flexibility for grant of stock options with an exercise price, at a discount to the prevailing market price. • Although, the vesting may be performance based, there is no disclosure on the performance metrics, weights, targets and threshold for determining the vesting outcome.
    19 for2 against

Mutual fund votes, meeting of 30 Jul 2024, 16 fund houses

  • To receive, consider and adopt the Audited Standalone Financial statements of the Company for the Financial Year ended March 31, 2024, the reports of the Auditors and Board of Directors thereon and the Audited Consolidated Financial statements of the Company for the Financial Year ended March 31, 2024 and the report of the Auditors thereon.MoreLess
    16 for0 against
  • To declare dividend of ₹ 3/- per Equity Share for the Financial Year ended March 31, 2024.
    16 for0 against
  • To appoint a Director in place of Dr. Ramesh Kancharla (DIN: 00212270), who retires by rotation
    Against Groww Mutual Fund, PGIM India Mutual Fund
    • Groww Mutual Fund, PGIM India Mutual FundCompliant with Law. Governance Concern: Combined position of Board Chairperson and Managing Director.
    14 for2 against
  • To approve the remuneration payable to Dr. Ramesh Kancharla, Chairman and ManagingnDirector of the Company.
    Against Groww Mutual Fund, PGIM India Mutual Fund
    • Groww Mutual Fund, PGIM India Mutual FundCompliant with Law. Governance Concern: Combined position of Board Chairperson and Managing Director.
    14 for2 against
  • To approve the remuneration payable to Dr. Dinesh Kumar Chirla, Whole-Time Directornof the Company.
    16 for0 against
  • To ratify the remuneration payable to Cost Auditors for the Financial Year 2024-25.
    16 for0 against

Mutual fund votes, meeting of 16 Mar 2024, 16 fund houses

  • Appointment of Dr. Adarsh Kancharla (DIN: 08302615), as a Non-Executive Director of the Company
    Against Axis Mutual Fund, DSP Mutual Fund, HDFC Mutual Fund, HSBC Mutual Fund
    • Axis Mutual FundDr. Adarsh Kancharla, 27, is the son of promoter and Managing Director, Ramesh Kancharla. He has been working with Rainbow Children’s Hospital after his post-graduation in Pediatrics from Sri Ramachandra Institute, Chennai in 2022. While his appointment is in line with the statutory requirements, the aggregate work experience is less than the vintage and experience of company's own and corporate industry board composition.
    • DSP Mutual FundDr. Adarsh Kancharla, 27, is the son of promoter and Managing Director, Ramesh Kancharla. He has been working with Rainbow Children’s Hospital after his post-graduation in Pediatrics from Sri Ramachandra Institute, Chennai in 2022. The company must clarify whether Dr. Adarsh Kancharla is in full-time employment with the company. While his appointment is in line with the statutory requirements, we note that with an aggregate work experience of less than ten years, his reappointment does not align with our voting guidelines.
    • HDFC Mutual FundWe believe that he does not have the requisite experience to be inducted in the board.
    • HSBC Mutual FundA vote AGAINST the nominee is warranted given his limited work experience as questions could be raised around his potential contribution to the board.
    12 for4 against

Mutual fund votes, meeting of 23 Dec 2023, 15 fund houses

  • Re-appointment of Mr. Aluri Srinivasa Rao (DIN: 00147058), as an Independent Director of the Company for a term of Five (5) years commencing from March 15, 2024.
    15 for0 against

Mutual fund votes, meeting of 29 Jun 2023, 13 fund houses

  • To receive, consider and adopt the Audited Standalone Financial statements of the Company for the Financial Year ended March 31, 2023, the reports of the Auditors and Board of Directors thereon and the Audited Consolidated Financial statements of the Company for the Financial Year ended March 31, 2023 and the report of the Auditors thereon.MoreLess
    13 for0 against
  • To declare dividend of ₹ 3/- per Equity Share for the Financial Year ended March 31, 2023.
    13 for0 against
  • To appoint a Director in place of Dr. Dinesh Kumar Chirla (DIN: 01395841), who retires by rotation and being eligible offers himself for re-appointment.
    13 for0 against
  • To appoint M/s. S.R. Batliboi & Associates LLP (Firm Registration No. 101049W/ E300004), Chartered Accountants, as Statutory Auditors for a term of 5 (five) consecutive years and to fix their remuneration.MoreLess
    13 for0 against
  • nTo re-appoint Dr. Anil Dhawan (DIN: 08191702), as an Independent Director of the Company for a term of 5 (Five) years commencing from August 30, 2023.n
    13 for0 against
  • To ratify the remuneration payable to Cost Auditors for the Financial Year 2023-24.
    13 for0 against

Each fund house counted once, from its own disclosure; the reasons are its own words.

Investor complaints and compliance

Quarter by quarter.

Investor complaints received and resolved, the company's own count

  • Received
  • Resolved

Open at the quarter's end

None open at any quarter's end.
The board is made up as the listing rules require
Yes
The board has a regular chairperson
Yes
The company has a risk management committee
Yes
The chair is related to the managing director
Yes
The filing has a part on fines and penalties
No
The filing has a part on tax disputes
No
There was a cyber security incident in the quarter
No

The company's own answers in its filing.

How money raised was used

Reported for the quarter to Mar 2025. The company's results filing for the quarter to Jun 2026 says no statement of how money raised was used applies to it.

RaisedAmount raisedForSet asideSpentSpent elsewhere
Public IssuesMay 2022, checked by HDFC Bank Limited1,580.85Early redemption of Non-Convertible Debentures NCDs issued by our Company to CDC Emerging Markets Limited CDCEML one of our Group Companies in full40.0040.00No
Public IssuesMay 2022, checked by HDFC Bank Limited1,580.85Capital expenditure towards setting up of new hospitals and purchase of medical equipment for such new hospitals170.00170.00No
Public IssuesMay 2022, checked by HDFC Bank Limited1,580.85General Corporate purposes57.6156.11No
₹ crore. Checked by is the agency appointed to monitor how the money is used. The reason and the comments are the company's, its audit committee's and its auditors' own words.